Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05598398 · ClinicalTrials.gov registry record · Phase 4
NPWTi on Closure of Chronic Pressure Sores
A Phase 4 study of Pressure Sore, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT05598398: Recruiting Phase 4 study of Pressure Sore, sponsored by Northwestern University.
NCT05598398 is a Phase 4 study of Pressure Sore that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 62 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05598398, a Phase 4 study of Pressure Sore, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-label study, we hope to show that the NPWTi system more effectively closes pressure sores following debridement than traditional care.
Primary Outcome
Record the number of days spent in the hospital from initial debridement (first visit with plastic surgeon) to discharge from hospital following surgery
Conditions Studied
Interventions
- DEVICE V.A.C.Ulta™ Negative Pressure Wound Therapy System
- OTHER Standard of Care (Wet-to-dry dressings)
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2025-10 |
| Phase | Phase 4 |
What NCT05598398 shows while recruiting
NCT05598398 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Pressure Sore appearing as the primary indexed condition, and to 2 interventions - of which V.A.C.Ulta™ Negative Pressure Wound Therapy System is the first listed.
NCT05598398 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05598398 about?
NCT05598398 is a clinical study titled "NPWTi on Closure of Chronic Pressure Sores". The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-labe...
What is the current status of trial NCT05598398?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2022-09-26. Estimated completion is 2025-10.
What conditions does trial NCT05598398 study?
This clinical trial studies the following conditions: Pressure Sore.
What interventions are being tested in trial NCT05598398?
The interventions under investigation include: V.A.C.Ulta™ Negative Pressure Wound Therapy System (DEVICE), Standard of Care (Wet-to-dry dressings) (OTHER).
Who is sponsoring clinical trial NCT05598398?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05598398 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05598398's enrollment target sits among peer trials
62 1110th of 2000 higher than 883 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI